| Drug Name: | Pertuzumab |
|---|
| Drug Class: | Monoclonal antibody |
|---|
| Mechanism of Action: | Binds to HER2 receptors on cancer cells, preventing them from signaling for cell growth and division |
|---|
| Use: | - Treatment of HER2-positive breast cancer
- Used in combination with trastuzumab and chemotherapy
|
|---|
| Side Effects: | - Diarrhea
- Nausea
- Fatigue
- Hair loss
- Decreased white blood cell count
|
|---|
| Contraindications: | - Hypersensitivity to pertuzumab or any component of the formulation
- Severe infusion-related reactions
|
|---|
| Specialty: | |
|---|